The role of oxidative stress, impaired glycolysis and mitochondrial respiratory redox failure in the cytotoxic effects of 6-hydroxydopamine in vitro

Mazzio, Elizabeth; Reams, Renee; Soliman, Karam F.A.

doi:10.1016/j.brainres.2003.12.034

Cited by 93 publications

(66 citation statements)

References 40 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Other investigators have shown that in vitro exposure to 6-OHDA increases oxidative stress and may lead to apoptosis (Kumar et al, 1995,Park et al, 2002,Soto-Otero et al, 2002,Holtz and O'Malley, 2003,Salinas et al, 2003,Ugarte et al, 2003,Zhuo et al, 2003,Datla et al, 2004,Elkon et al, 2004,Mazzio et al, 2004, and some elements of apoptosis and degeneration occur shortly after in vivo administration of 6-OHDA (Jeon et al, 1995,Joo et al, 1998,Zuch et al, 2000,Kramer and Mytilineou, 2004,Mladenovic et al, 2004. However, little has been reported on in vivo markers of oxidative stress after 6-OHDA administration.…”

Section: Discussionmentioning

confidence: 99%

“…Many investigators have demonstrated that 6-OHDA induces oxidative stress (Kumar et al, 1995,Soto-Otero et al, 2000,Seth et al, 2002,Soto-Otero et al, 2002,Mazzio et al, 2004, which can lead to the induction of apoptosis and cellular loss (Choi et al, 1999,Marti et al, 2002,Seth et al, 2002. The effects of 6-OHDA are agedependent as there is a greater effect seen in aged animals compared to young animals, particularly with lower doses of 6-OHDA (Marshall et al, 1983,Cass et al, 2002.…”

Section: Nih Public Accessmentioning

confidence: 99%

See 1 more Smart Citation

Oxidative stress and dopamine depletion in an intrastriatal 6-hydroxydopamine model of Parkinson’s disease

Smith

Cass

2007

Neuroscience

View full text Add to dashboard Cite

Although the etiology of Parkinson's disease (PD) is unknown, a common element of most theories is the involvement of oxidative stress, either as a cause or effect of the disease. There have been relatively few studies that have characterized oxidative stress in animal models of PD. In the present study a 6-hydroxydopamine (6-OHDA) rodent model of PD was used to investigate the in vivo production of oxidative stress after administration of the neurotoxin. 6-OHDA was injected into the striatum of young adult rats and the production of protein carbonyls and 4-hydroxynonenal (HNE) was measured at 1, 3, 7, and 14 days after administration. A significant increase in both markers was found in the striatum 1 day after neurotoxin administration, and this increase declined to basal levels by day 7. There was no significant increase found in the substantia nigra at any of the time points investigated. This same lesion paradigm produced dopamine depletions of 90-95% in the striatum and 63-80% in the substantia nigra by 14 to 28 days post 6-OHDA. Protein carbonyl and HNE levels were also measured in middle-aged and aged animals 1 day after striatal 6-OHDA. Both protein carbonyl and HNE levels were increased in the striatum of middle-aged and aged animals treated with 6-OHDA, but the increases were not as great as those observed in the young adult animals. Similar to the young animals, there were no increases in either marker in the substantia nigra of the middle-aged and aged animals. There was a trend for an age-dependent increase in basal amounts of oxidative stress markers when comparing the non-lesioned side of the brains of the three age groups. These results support that an early event in the course of dopamine depletion following intrastriatal 6-OHDA administration is the generation of oxidative stress. Keywordsreactive oxygen species; protein carbonyls; 4-hydroxynonenal; striatum; substantia nigra; aging; Fischer-344 rat Parkinson's disease (PD) stems from the loss of dopamine (DA) caused by the degeneration of the dopaminergic neurons of the substantia nigra. The nature of this degeneration remains unclear, although current theories suggest that reactive oxygen species (ROS) are involved in some capacity early in the disease process (Jenner, 2003). One of the earliest changes in patients with PD and incidental Lewy body disease is the loss of glutathione (Sian et al., 1994,Owen et al., 1996. Post mortem tissue from PD patients has been shown to contain elevated levels Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. (Yoritaka et al., 1996), protein carbonyls (Alam et...

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Nih Public Accessmentioning

confidence: 99%

Oxidative stress and dopamine depletion in an intrastriatal 6-hydroxydopamine model of Parkinson’s disease

Smith

Cass

2007

Neuroscience

View full text Add to dashboard Cite

show abstract

“…Once inside neurons, 6-OHDA is readily oxidized in reactive oxygen species leading to electron transport chain inhibition and oxidative stress. 68 6-OHDA is usually injected unilaterally in the substantia nigra or in the striatum (retrograde degeneration). The unilateral injection allows the evaluation of neuron cell death and molecular parameters in the lesion hemisphere compared with the intact contralateral one.…”

Section: Animal Models Of Parkinson's Diseasementioning

confidence: 99%

Animal models of neurodegenerative diseases

Ribeiro

Camargos

Souza

et al. 2013

Rev. Bras. Psiquiatr.

View full text Add to dashboard Cite

“…In fact, it was reported that dopamine and its metabolites are able to induce toxicity in dopaminergic cells via mechanisms that range from an oxidative stress phenomenon (Fahn and Cohen, 1992;Rabinovic et al, 2000) to specific modifications of critical proteins, such as the covalent modification of parkin (LaVoie et al, 2005), triggering apoptotic death in various neuronal cultures (Jones et al, 2000;Lamensdorf et al, 2000a;Kristal et al, 2001;Lotharius et al, 2005;Mazzio et al, 2004).…”

Section: Introductionmentioning

confidence: 99%

3,4-Dihydroxyphenylacetic acid (DOPAC) modulates the toxicity induced by nitric oxide in PC-12 cells via mitochondrial dysfunctioning

2008

View full text Add to dashboard Cite

The role of oxidative stress, impaired glycolysis and mitochondrial respiratory redox failure in the cytotoxic effects of 6-hydroxydopamine in vitro

Cited by 93 publications

References 40 publications

Oxidative stress and dopamine depletion in an intrastriatal 6-hydroxydopamine model of Parkinson’s disease

Oxidative stress and dopamine depletion in an intrastriatal 6-hydroxydopamine model of Parkinson’s disease

Animal models of neurodegenerative diseases

3,4-Dihydroxyphenylacetic acid (DOPAC) modulates the toxicity induced by nitric oxide in PC-12 cells via mitochondrial dysfunctioning

Contact Info

Product

Resources

About